Search Results - Almasoud, Abdulrahman
- Showing 1 - 8 results of 8
-
1
-
2
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines by Alharbi, Naif Khalaf, Al-Tawfiq, Jaffar A, Alwehaibe, Amal, Alenazi, Mohamed W, Almasoud, Abdulrahman, Algaisi, Abdullah, Alhumaydhi, Fahad A, Hashem, Anwar M, Bosaeed, Mohammed, Alsagaby, Suliman A
Published 2022Text -
3
Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area by Alroqi, Fayhan, Masuadi, Emad, Alabdan, Lulwah, Nogoud, Maysa, Aljedaie, Modhi, Abu-Jaffal, Ahmad S., Barhoumi, Tlili, Almasoud, Abdulrahman, Alharbi, Naif Khalaf, Alsaedi, Abdulrahman, Khan, Mohammad, Arabi, Yaseen M., Nasr, Amre
Published 2021Text -
4
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl... by Hashem, Anwar M, Algaissi, Abdullah, Agrawal, Anurodh Shankar, Al-amri, Sawsan S, Alhabbab, Rowa Y, Sohrab, Sayed S, S. Almasoud, Abdulrahman, Alharbi, Naif Khalaf, Peng, Bi-Hung, Russell, Marsha, Li, Xuguang, Tseng, Chien-Te K
Published 2019Text -
5
Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 by Degnah, Afnan A., Al-amri, Sawsan S., Hassan, Ahmed M., Almasoud, Abdulrahman S., Mousa, Manar, Almahboub, Sarah A., Alhabbab, Rowa Y., Mirza, Ahmed A., Hindawi, Salwa I., Alharbi, Naif Khalaf, Azhar, Esam I., Hashem, Anwar M.
Published 2020Text -
6
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial by Bosaeed, Mohammad, Balkhy, Hanan H, Almaziad, Sultan, Aljami, Haya A, Alhatmi, Hind, Alanazi, Hala, Alahmadi, Mashael, Jawhary, Ayah, Alenazi, Mohammed W, Almasoud, Abdulrahman, Alanazi, Rawan, Bittaye, Mustapha, Aboagye, Jeremy, Albaalharith, Nahla, Batawi, Sarah, Folegatti, Pedro, Ramos Lopez, Fernando, Ewer, Katie, Almoaikel, Khalid, Aljeraisy, Majed, Alothman, Adel, Gilbert, Sarah C, Khalaf Alharbi, Naif
Published 2022Text -
7
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels by Alharbi, Naif Khalaf, Qasim, Ibrahim, Almasoud, Abdulrahman, Aljami, Haya A., Alenazi, Mohamed W., Alhafufi, Ali, Aldibasi, Omar S., Hashem, Anwar M., Kasem, Samy, Albrahim, Raed, Aldubaib, Musaad, Almansour, Ali, Temperton, Nigel J., Kupke, Alexandra, Becker, Stephan, Abu-obaidah, Ali, Alkarar, Ali, Yoon, In-Kyu, Azhar, Esam, Lambe, Teresa, Bayoumi, Faisal, Aldowerij, Ali, Ibrahim, Osman H., Gilbert, Sarah C., Balkhy, Hanan H.
Published 2019Text -
8
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals by Alserehi, Haleema Ali, Alqunaibet, Ada Mohammed, Al-Tawfiq, Jaffar A., Alharbi, Naif Khalaf, Alshukairi, Abeer Nizar, Alanazi, Khalid Hamdan, Bin Saleh, Ghada Mohammed, Alshehri, Amer Mohammed, Almasoud, Abdulrahman, Hashem, Anwar M., Alruwaily, Amaal Rabie, Alaswad, Rehab Habeeb, Al-Mutlaq, Hind Mohammed, Almudaiheem, Abdulllah Ali, Othman, Fatmah Mahmoud, Aldakeel, Sumyah Abdullah, Abu Ghararah, Mouath Rashid, Jokhdar, Hani Abdulaziz, Algwizani, Abdullah Rshoud, Almudarra, Sami Saeed, Albarrag, Ahmed Mohammed
Published 2021Text